Skip to main content
Walter Noordzij
dr.

In my profession as a nuclear medicine physician, I’m involved in both clinical and scientific applications of nuclear medicine and radiology modalities. My main interests include haematology, general oncology, radio-immunotherapy, and especially the implementation of new therapeutic strategies. Currently, I have a special interest in imaging post-transplant lymphoproliferative disease, as well as radio-immunotherapy in chemotherapy refractory (non)-Hodgkin’s lymphoma.

Nuclear imaging in proliferative angiopathy
Published in: European Journal of Nuclear Medicine and Molecular Imaging
S E M Kolderman, W Noordzij, J.M.C. van Dijk, G.J.R. Luijckx
Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis
Published in: Amyloid: Journal of protein folding disorders
Objective: To assess the usefulness of bone scintigraphy with (99m)Technetium-hydroxymethylene diphosphonate (Tc-99m-HDP) for the detection of cardiac involvement in a group of patients with ATTR amyloidosis in different phases of disease, to relate the findings to echocardiography, ECG and cardiac biomarkers, and to evaluate different bone scintigraphic techniques and calculation methods for quantification of the cardiac uptake and for correlation with echocardiographic features and cardiac biomarkers. Methods: Forty-one patients underwent clinical examinations, echocardiography, ECG, measurement of cardiac biomarkers and bone scintigraphy (planar imaging and SPECT-CT) and were subsequently...
Gastrocolocutaneous fistula detected by [F-18]fluorodeoxyglucose positron emission tomography with low-dose computed tomography: a rare iatrogenic complication of colonoscopy
Published in: Endoscopy
Utility of F-18-FDG PET(/CT) in patients with systemic and localized amyloidosis
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Purpose Amyloidosis is a group of diseases characterized by deposition of fibrils and this deposition may be localized or systemic. The presence of giant cells is typical of localized AL amyloidosis in contrast to systemic amyloidosis. Because of this presence of giant cells we hypothesize that F-18-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) may show uptake in localized amyloidosis but not in systemic amyloidosis. The aim of the study was to evaluate the utility of F-18-FDG PET/CT in distinguishing systemic amyloidosis from localized amyloidosis. Methods A retrospective search...
Fluorine-18 labeled fluorodeoxyglucose PET useful for therapy monitoring in localized AL amyloidosis?
Published in: Amyloid: Journal of protein folding disorders